Temasek Holdings’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Temasek Holdings’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,793,376	Closed	-$34.2M	–	61
2020 Q1	$34.2M	Hold	4,793,376	–	–	0.25%	38
2019 Q4	$114M	Sell	4,793,376 -380,792	-7%	-$10.5M	0.75%	25
2019 Q3	$139M	Hold	5,174,168	–	–	1.02%	19
2019 Q2	$140M	Hold	5,174,168	–	–	1%	21
2019 Q1	$180M	Hold	5,174,168	–	–	1.24%	20
2018 Q4	$101M	Hold	5,174,168	–	–	0.7%	25
2018 Q3	$138M	Hold	5,174,168	–	–	0.8%	27
2018 Q2	$195M	Buy	5,174,168 +290,600	+6%	+$11.1M	1.03%	22
2018 Q1	$159M	Hold	4,883,568	–	–	0.87%	25
2017 Q4	$238M	Hold	4,883,568	–	–	1.46%	15
2017 Q3	$264M	Hold	4,883,568	–	–	1.54%	13
2017 Q2	$274M	Sell	4,883,568 -1,700,000	-26%	-$68.1M	1.77%	10
2017 Q1	$258M	Hold	6,583,568	–	–	1.92%	8
2016 Q4	$148M	Hold	6,583,568	–	–	1.18%	16
2016 Q3	$150M	Hold	6,583,568	–	–	1.21%	14
2016 Q2	$155M	Hold	6,583,568	–	–	1.21%	13
2016 Q1	$134M	Hold	6,583,568	–	–	1.06%	16
2015 Q4	$339M	Buy	6,583,568 +750,000	+13%	+$36.4M	2.57%	9
2015 Q3	$249M	Hold	5,833,568	–	–	2.36%	11
2015 Q2	$266M	Hold	5,833,568	–	–	1.66%	14
2015 Q1	$221M	Hold	5,833,568	–	–	1.66%	11
2014 Q4	$165M	Buy	5,833,568 +1,600,000	+38%	+$44.5M	1.72%	13
2014 Q3	$107M	Hold	4,233,568	–	–	1.14%	14
2014 Q2	$124M	Hold	4,233,568	–	–	1.85%	10
2014 Q1	$110M	Hold	4,233,568	–	–	1.7%	9
2013 Q4	$109M	Hold	4,233,568	–	–	2.26%	8
2013 Q3	$113M	Hold	4,233,568	–	–	3.13%	6
2013 Q2	$104M	Buy	+4,233,568	New	+$84.1M	2.64%	9

Other funds holding PTLA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

WIC

Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return

Temasek Holdings's PTLA Position: Q2 2020 in Review

Temasek Holdings sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 4,793,376 shares — an estimated $34.2M sold.

Temasek Holdings first reported a position in PTLA in Q2 2013 and held it in 28 quarters. The position peaked at $339M in Q4 2015. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

Temasek Holdings reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Temasek Holdings sold 4,793,376 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $34.2M.
Temasek Holdings first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 28 quarters.
Temasek Holdings's Portola Pharmaceuticals, Inc. position peaked at $339M in Q4 2015.
162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Temasek Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.